Preview

Russian Journal of Cardiology

Advanced search

May Measurement Month 2019: adherence to treatment and hypertension control in Russia

https://doi.org/10.15829/1560-4071-2020-3-3745

Abstract

The International Society of Hypertension and the World Hypertension League initiated a blood pressure screening study called May Measurement Month 2019 (MMM19) to improve the detection of elevated blood pressure (BP) and to assess BP control in patients with hypertension (HTN).

Aim. To assess adherence to treatment of the hypertensive population according to MMM19 campaign in Russia.

Material and methods. During May 2019, 5394 people from 21 regions of Russia took part in the screening. Participation was voluntary and did not imply gender restrictions; all subjects were over 18 years of age. During the screening, BP was measured three times using electronic and mechanical sphygmomanometers, as well as a questionnaire on the diabetes, history of cardiovascular events, smoking, and alcohol consumption was filled. Information was also collected on the date of last BP check and the administration of statins, acetylsalicylic acid and antihypertensive drugs. Data on height and body weight was obtained from respondents.

Results. The analysis included data from 5274 participants aged 18 to 96 years (men — 1834 (34,8%)). Median age was 25 years, quartiles — 20 and 49 years. According to MMM19 data, the proportion of HTN patients in the Russian population was 31,9%, and with the exception of participants under 25 years old — 51,5%. Patients with HTN over 25 years old take antihypertensive therapy in 73,6%; 38,6% are characterized by irregular drug intake. Only 11,8% of men and 17,2% of women reach the target blood pressure <130/80 mm Hg. Only 20-30% of patients who used 4-5 antihypertensives reached the target BP level.

Conclusion. According to MMM19 in Russia, only a third of high-risk patients measured BP over the past 12 months. There is also low adherence to antihypertensive therapy and inadequate control of HTN. Patients with HTN and a history of cardiovascular events are more likely to take antihypertensives regularly.

About the Authors

O. P. Rotar
Almazov National Medical Research Center; ITMO University
Russian Federation

St. Petersburg

ResearcherID: A-3670-2014




K. M. Tolkunova
Almazov National Medical Research Center
Russian Federation

St. Petersburg

ResearcherID: ААВ-4484-2020




V. N. Solntsev
Almazov National Medical Research Center
Russian Federation

St. Petersburg

ResearcherID: H-2707-2013




A. M. Erina
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAH-1857-2019




M. A. Boyarinova
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAH-2738-2019




A. S. Alieva
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAH-2371-2019




E. V. Moguchaya
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAH-3802-2019




E. P. Kolesova
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAH-2492-2019




E. I. Pavlyuk
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AA-5267-2020




O. M. Posnenkova
V.I. Razumovsky Saratov State Medical University

Saratov

ResearcherID: B-5627-2015




O. V. Abrosimova
Saratov State Technical University

Saratov

ResearcherID: AAB-7688-2020




O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine

Moscow

ResearcherID: G-8443-2016




R. N. Shepel
National Medical Research Center for Therapy and Preventive Medicine

Moscow

ResearcherID: G-8380-2016




E. S. Ivanova
National Medical Research Center for Therapy and Preventive Medicine

Moscow

ResearcherID: AAB-2701-2020




L. M. Zhamalov
National Medical Research Center for Therapy and Preventive Medicine

Moscow

ResearcherID: AAB-2836-2020




M. I. Ivanova
I.I. Mechnikov North-Western State Medical University

St. Petersburg

ResearcherID: ААВ-3258-2020




D. S. Evdokimov
I.I. Mechnikov North-Western State Medical University

St. Petersburg

ResearcherID: ААВ-3172-2020




S. A. Boldueva
I.I. Mechnikov North-Western State Medical University

St. Petersburg

ResearcherID: AAH-3862-2019




T. I. Yakunchenko
Belgorod National Research University

Belgorod

ResearcherID: AAB-5612-2020




O. V. Mevsha
Belgorod National Research University

Belgorod

ResearcherID: AAB-5315-2020




M. N. Petrova
North-Eastern Federal University

Yakutia

ResearcherID: F-8712-2014




Z. A. Pokoeva
Chita State Medical Academy

Chita

ResearcherID: AAB-6519-2020




T. V. Kalinkina
Chita State Medical Academy

Chita

ResearcherID: AAB-5276-2020




M. E. Statsenko
Volgograd State Medical University

Volgograd

ResearcherID: P-2769-2015




M. V. Derevyanchenko
Volgograd State Medical University

Volgograd

ResearcherID: A-1859-2016




Yu. M. Lopatin
Volgograd State Medical University

Volgograd

ResearcherID: B-2804-2017




M. M. Petrova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Krasnoyarsk

ResearcherID: L-5623-2014




D. S. Kaskaeva
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Krasnoyarsk

ResearcherID: S-8106-2016




A. A. Chernova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Krasnoyarsk

ResearcherID: F-3814-2016




S. Yu. Nikulina
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Krasnoyarsk

ResearcherID: N-7054-2014




O. V. Kaplieva
Far-Eastern State Medical University

Khabarovsk

ResearcherID: AAB-3552-2020




A. O. Mikhaylichenko
Far-Eastern State Medical University

Khabarovsk

ResearcherID: AAB-3549-2020




O. E. Latkin
Far-Eastern State Medical University

Khabarovsk

ResearcherID: AAB-3559-2020




E. A. Smirnova
I.P. Pavlov Ryazan State Medical University

Ryazan

ResearcherID: Y-1235-2018




Yu. A. Kholodkova
Ryazan Regional Clinical Cardiology Dispensary

Ryazan

ResearcherID: AAB-6614-2020



V. P. Mikhin
Kursk State Medical University

Kursk

ResearcherID: G-4776-2013




O. G. Novokreshchennyh
N.A. Semashko Republican Clinical Hospital

Ulan-Ude, Republic of Buryatia

ResearcherID: AAB-3682-2020




E. M. Dolya
V.I. Vernadsky Crimean Federal University, S. I. Georgievsky Medical Academy

Simferopol, Republic of Crimea

ResearcherID: AAB-5326-2020




N. S. Gaffarov
V.I. Vernadsky Crimean Federal University, S. I. Georgievsky Medical Academy

Simferopol, Republic of Crimea

ResearcherID: AAB-3299-2020




M. E. Yevsevieva
Stavropol State Medical University

Stavropol

ResearcherID: U-4053-2017




E. N. Fursova
Stavropol State Medical University

Stavropol

ResearcherID: AAB-5018-2020




E. V. Italintseva
Stavropol State Medical University

Stavropol

ResearcherID: S-1125-2016




O. V. Sergeeva
Stavropol State Medical University

Stavropol

ResearcherID: AAB-6298-2020




E. R. Makeeva
City Clinical Hospital № 1

Ulyanovsk

ResearcherID: AAB-4811-2020




I. I. Nurtdinova
Ulyanovsk State University

Ulyanovsk

ResearcherID: AAB5017-2020




L. M. Tagirova
Ulyanovsk State University

Ulyanovsk

ResearcherID: ААВ-4904-2020




E. K. Bukharova
Tomsk National Research Medical Center

Tomsk

ResearcherID: ААВ-4737-2020




T. M. Ripp
Tomsk National Research Medical Center

Tomsk

ResearcherID: P-6586-2015




V. F. Mordovin
Tomsk National Research Medical Center
Russian Federation

Tomsk

ResearcherID: F-8913-2017




A. M. Kochergina
Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical University

Kemerovo

ResearcherID: I-6495-2017




V. O. Leonova
Kemerovo State Medical University

Kemerovo

ResearcherID: AAB-3574-2020




I. M. Okunev
Research Institute for Complex Issues of Cardiovascular Diseases

Kemerovo

ResearcherID: AAB-3572-2020




Yu. A. Sharapova
N. N. Burdenko Voronezh State Medical University

Voronezh

ResearcherID: AAB-5935-2020




A. A. Tanicheva
Almazov National Medical Research Center

St. Petersburg

ResearcherID: AAC-5213-2020




A. O. Konradi
Almazov National Medical Research Center

St. Petersburg

ResearcherID: P-1547-2014




E. V. Shlyakhto
Almazov National Medical Research Center

St. Petersburg

ResearcherID: A-6939-2014




References

1. Chazova IE, Oschepkova EV. Results of the Federal (National) Project for prevention and treatment essential hypertension patients in Russia from 2002-2012 years. Vestn Ross Akad Med Nauk. 2013;2:4-11. (In Russdoi:10.15690/vramn.v68i2.542.

2. Ikeda N, Sapienza D, Guerrero R, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92:109. doi:10.2471/BLT.13.121954.

3. Rotar O, Konradi A, Shlyakhto E, et al. May Measurement Month 2017 in Russia: hypertension treatment and control — Europe. European Heart Journal Supplements. 2019;21 (Suppl D):D101-3. doi:10.1093/eurheartj/suz068.

4. Rotar OP, Tolkunova KM, Mevsha OV, et al. Screening blood pressure measurement in the Russian population (the results of the МММ17 activity). Hypertension. 2018;24(4):44858. (In Russ.) doi:10.18705/1607419X-2018-24-4-448-458.

5. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.

6. Fomin IV, Polyakov DS, Badin YuV, et аl. Arterial hypertension in European Russia from 1998 to 2007: What did we achieve at the population level? Russian Heart Journal. 2016;15(5):369-78. (In Russ.) doi:10.18087/RHJ.2016.5.2240.

7. Badin YuV, Fomin IV, Belenkov YuN, et al. EPOCHA-AH 1998-2017. Dynamics of prevalence, awareness of arterial hypertension, treatment coverage, and effective control of blood pressure in the European part of the Russian Federation. Kardiologiia. 2019;59(1S):34-42. (In Russ.) doi:10.18087/cardio.2445.

8. Fofanova TV, Orlova YA, Patrusheva IF, et al. The Use of Felodipine in Ambulatory Practice: Assessment of Clinical Efficacy and Compliance in Patients With Arterial Hypertension. RMJ. 2009;17(5):392-6. (In Russ.) doi:10.18087/cardio.2017.7.10004.

9. Akesson A, Larsson SC, Discacciati A, et al. Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in Men A Population-Based Prospective Cohort Study. J Am Coll Cardiol. 2014;64(13):1299-306. doi:10.1016/j.jacc.2014.06.1190.

10. Morozova TE, Andrushchishina TB. Arterial hypertension in patients with diabetes: An individualized choice of antihypertensive medications. Russ J Cardiol. 2011;(2):72-7. (In Russ.) doi:10.15829/1560-4071-2011-2-72-77.

11. Leonova MV, Belousov YuB, Shteinberg LL, et al. The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (hypertensive patients survey). Systemic Hypertension. 2015;12(3):11-8. (In Russ.)

12. Langsted A, Freiberg JJ, Nordestgaard BG. Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014. Atherosclerosis. 2017;257:9-15. doi:10.1016/j.atherosclerosis.2016.11.025.

13. Ridker P, Danielson E, Fonseca F, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. The New England Journal of Medicine. 2008;359:2195-207. doi:10.1056/NEJMoa0807646.

14. Smirnova MD, Ageev FT. Statins — old myths and new facts. RMJ. 2017;20:1421-8. (In Russ.)

15. eHealth Action Plan 2012-2020 — Innovative Healthcare for the 21st Century. URL: http://ec.europa.eu/health//sites/health/files/ehealth/docs/com_2012_736_en.pdf.

16. About Digital Health. 2017. URL: http://www.cocir.org/index.php?id=147.

17. About Telemedicine. 2017. URL: http://www.cocir.org/index.php?id=103.

18. About mHealth. 2017. URL: http://www.cocir.org/index.php?id=175.

19. Perroy AC. M‑health in an age of E‑health. Promises, challenges and liabilities Annales Pharmaceutiques Francaises. 2016;4(6):421-30. doi:10.1016/j.pharma.2016.03.002.

20. Kochergin NA, Kochergina AM, Kilina IR, et al. Possibility of mobile application usage as a tool to improve compliance for patients with cardiovascular disease. Information technologies for the Physician. 2017;2:73-9. (In Russ.)


Review

For citations:


Rotar O.P., Tolkunova K.M., Solntsev V.N., Erina A.M., Boyarinova M.A., Alieva A.S., Moguchaya E.V., Kolesova E.P., Pavlyuk E.I., Posnenkova O.M., Abrosimova O.V., Drapkina O.M., Shepel R.N., Ivanova E.S., Zhamalov L.M., Ivanova M.I., Evdokimov D.S., Boldueva S.A., Yakunchenko T.I., Mevsha O.V., Petrova M.N., Pokoeva Z.A., Kalinkina T.V., Statsenko M.E., Derevyanchenko M.V., Lopatin Yu.M., Petrova M.M., Kaskaeva D.S., Chernova A.A., Nikulina S.Yu., Kaplieva O.V., Mikhaylichenko A.O., Latkin O.E., Smirnova E.A., Kholodkova Yu.A., Mikhin V.P., Novokreshchennyh O.G., Dolya E.M., Gaffarov N.S., Yevsevieva M.E., Fursova E.N., Italintseva E.V., Sergeeva O.V., Makeeva E.R., Nurtdinova I.I., Tagirova L.M., Bukharova E.K., Ripp T.M., Mordovin V.F., Kochergina A.M., Leonova V.O., Okunev I.M., Sharapova Yu.A., Tanicheva A.A., Konradi A.O., Shlyakhto E.V. May Measurement Month 2019: adherence to treatment and hypertension control in Russia. Russian Journal of Cardiology. 2020;25(3):3745. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3-3745

Views: 3712


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)